Citeline Podcasts

Chapter 1: An Introduction by Citeline

Incoming APACMed chair John Collings Outlines Regional Medtech Priorities by Citeline

CanSino’s Yu discusses its approval of Covidecia Air, the world’s first inhaled COVID-19 vaccine, overseas clinical trials and its original Ad5-nCOV vaccine Covidecia commercial launch in emerging markets.

https://scrip.pharmaintelligence.informa.com/SC147139/Quick-Listen-Scrips-Five-MustKnow-Things

Pink Sheet reporters and editors discuss the newly approved ALS drug Relvyrio, the promising data on the Alzheimer’s drug lecanemab, and CMS’s efforts to build the drug price negotiation program

Learn the short- and long-term benefits and considerations for incorporating the use of real-world data (RWD) early on in clinical research.

In the second episode featuring highlights from a recent panel on mRNA manufacturing, experts from BioNTech, Sanofi, eTheRNA, IAVI and TriLink Biotechnologies will discuss the role of stability, CDMO partnerships, emerging mRNA platforms and the importance of locking these down early.

Following the global pandemic and success of mRNA technology in vaccines immunizing against severe COVID-19 infections, a panel of experts from BioNTech, Sanofi, eTheRNA, IAVI and TriLink Biotechnologies came together to discuss how industry can ease the bottlenecks that currently exist to wider usage of mRNA. The first of two podcast episodes featuring highlights will focus on strengthening supply chains, drug substance and drug product manufacturing.

Understand the history, journey, and implications of the Prescription Drug Fee User Act (PDFUA) as it approaches its deadline for renewal.

Explore real-world data (RWD) quality and curation considerations beyond the guidance offered by US FDA to overcome common data processing pitfalls.